ALB and neoplasm: Considering the numerous advantages of albumin NPs as drug carriers, including biodegradability, biocompatibility, non-immunogenicity, and long half-life, as well as the successful launch of Abraxane® and Fyarro®, albumin NPs hold great promise in the targeted delivery of anti-tumor drugs.